Download PDF
J Neurol Surg Rep 2015; 76(01): e65-e71
DOI: 10.1055/s-0034-1396656
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Rare Presentation of Giant Cell Tumor in the Internal Auditory Canal: Case Report and Review of the Literature

Ajit S. Jada
1   Department of Neurosurgery, Montefiore Medical Center, Bronx, New York, United States
,
Raj K. Shrivastava
2   Department of Neurosurgery, The Mount Sinai Medical Center, New York, New York, United States
,
Abul Mannan
3   Department of Pathology, The Mount Sinai Medical Center Roosevelt Division, New York, New York, United States
,
Andrew Kobets
1   Department of Neurosurgery, Montefiore Medical Center, Bronx, New York, United States
,
Spiros Manolidis
4   Department of Otolaryngology, The Mount Sinai Medical Center Roosevelt Division, New York, New York, United States
› Author Affiliations
Further Information

Publication History

03 July 2014

22 October 2014

Publication Date:
18 February 2015 (online)

Also available at
   Permissions and Reprints

Abstract

Giant cell tumor (GCT) is a benign but locally aggressive bone tumor that usually involves the end of long bones. It is a relatively common neoplasm in patients, constituting 5 to 10% of all benign bone tumors. Approximately 2% of GCTs occur in the craniofacial skeleton with a predilection for the ethmoid, sphenoid, and temporal bones. The skull base location is unique and not commonly described. Hearing loss, headache, tinnitus, and subcutaneous masses are the most commonly reported symptoms in GCTs of the skull base. In this case report we present the first description of a GCT within the internal auditory canal causing cranial neuropathy and review the recent pertinent literature.

Keywords

giant cell tumor - internal auditory canal - skull base tumor
 

  • References

  • 1 Boons HW, Keijser LC, Schreuder HW, Pruszczynski M, Lemmens JA, Veth RP. Oncologic and functional results after treatment of giant cell tumors of bone. Arch Orthop Trauma Surg 2002; 122 (1) 17-23
    CrossrefPubMedGoogle Scholar
  • 2 Dahlin DC, Unni KK. Bone Tumors: General Aspects and Data on 8,542 Cases. 4th ed. Springfield, IL: Charles C Thomas; 1986
    Google Scholar
  • 3 Wang HC, Chien SH, Lin GT. Management of grade III giant cell tumors of bones. J Surg Oncol 2005; 92 (1) 46-51
    CrossrefPubMedGoogle Scholar
  • 4 Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ. From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics 2001; 21 (5) 1283-1309
    CrossrefPubMedGoogle Scholar
  • 5 Szendröi M. Giant-cell tumour of bone. J Bone Joint Surg Br 2004; 86 (1) 5-12
    PubMedGoogle Scholar
  • 6 Marioni G, Marchese-Ragona R, Guarda-Nardini L , et al. Giant cell tumour (central giant cell lesion) of the maxilla. Acta Otolaryngol 2006; 126 (7) 779-781
    CrossrefPubMedGoogle Scholar
  • 7 Prasad SC, Piccirillo E, Nuseir A , et al. Giant cell tumors of the skull base: case series and current concepts. Audiol Neurootol 2014; 19 (1) 12-21
    CrossrefPubMedGoogle Scholar
  • 8 Isaacson B, Berryhill W, Arts HA. Giant-cell tumors of the temporal bone: management strategies. Skull Base 2009; 19 (4) 291-301
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Rock JP, Mahmood A, Cramer HB. Giant cell tumor of the skull base. Am J Otol 1994; 15 (2) 268-272
    PubMedGoogle Scholar
  • 10 Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM. Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am 1982; 64 (5) 755-761
    PubMedGoogle Scholar
  • 11 Blacklock JB, Weber RS, Lee YY, Goepfert H. Transcranial resection of tumors of the paranasal sinuses and nasal cavity. J Neurosurg 1989; 71 (1) 10-15
    CrossrefPubMedGoogle Scholar
  • 12 Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone 2008; 42 (1) 68-73
    CrossrefPubMedGoogle Scholar
  • 13 Thomas D, Henshaw R, Skubitz K , et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010; 11 (3) 275-280
    CrossrefPubMedGoogle Scholar
  • 14 Goldring SR, Schiller AL, Mankin HJ, Dayer JM, Krane SM. Characterization of cells from human giant cell tumors of bone. Clin Orthop Relat Res 1986; (204) 59-75
    PubMedGoogle Scholar
  • 15 Liao TS, Yurgelun MB, Chang SS , et al. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J Orthop Res 2005; 23 (1) 203-209
    CrossrefPubMedGoogle Scholar
  • 16 Hanaoka H, Friedman B, Mack RP. Ultrastructure and histogenesis of giant-cell tumor of bone. Cancer 1970; 25 (6) 1408-1423
    CrossrefPubMedGoogle Scholar
  • 17 Roux S, Mariette X. RANK and RANKL expression in giant-cell tumour of bone. Lancet Oncol 2010; 11 (6) 514
    PubMedGoogle Scholar
  • 18 Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 1998; 188 (5) 997-1001
    CrossrefPubMedGoogle Scholar
  • 19 Huang L, Xu J, Wood DJ, Zheng MH. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. Am J Pathol 2000; 156 (3) 761-767
    CrossrefPubMedGoogle Scholar
  • 20 Lacey DL, Tan HL, Lu J , et al. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol 2000; 157 (2) 435-448
    CrossrefPubMedGoogle Scholar
  • 21 Lacey DL, Timms E, Tan HL , et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93 (2) 165-176
    CrossrefPubMedGoogle Scholar
  • 22 Schlorf RA, Koop SH. Maxillary giant cell reparative granuloma. Laryngoscope 1977; 87 (1) 10-17
    PubMedGoogle Scholar
  • 23 Ciappetta P, Salvati M, Bernardi C, Raco A, Di Lorenzo N. Giant cell reparative granuloma of the skull base mimicking an intracranial tumor. Case report and review of the literature. Surg Neurol 1990; 33 (1) 52-56
    CrossrefPubMedGoogle Scholar
  • 24 Chang SS, Suratwala SJ, Jung KM , et al. Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis. Clin Orthop Relat Res 2004; (426) 103-109
    PubMedGoogle Scholar
  • 25 Leonard J, Gökden M, Kyriakos M, Derdeyn CP, Rich KM. Malignant giant-cell tumor of the parietal bone: case report and review of the literature. Neurosurgery 2001; 48 (2) 424-429
    CrossrefPubMedGoogle Scholar
  • 26 Pai SB, Lalitha RM, Prasad K, Rao SG, Harish K. Giant cell tumor of the temporal bone—a case report. BMC Ear Nose Throat Disord 2005; 5: 8
    CrossrefPubMedGoogle Scholar
  • 27 Auclair PL, Cuenin P, Kratochvil FJ, Slater LJ, Ellis GL. A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor. Oral Surg Oral Med Oral Pathol 1988; 66 (2) 197-208
    CrossrefPubMedGoogle Scholar
  • 28 Katz A, Hirschl S. Giant cell reparative granuloma in the temporal bone. Arch Otolaryngol 1974; 100 (5) 380-382
    CrossrefPubMedGoogle Scholar
  • 29 Hirschl S, Katz A. Giant cell reparative granuloma outside the jaw bone. Diagnostic criteria and review of the literature with the first case described in the temporal bone. Hum Pathol 1974; 5 (2) 171-181
    CrossrefPubMedGoogle Scholar
  • 30 Saw S, Thomas N, Gleeson MJ, Bódi I, Connor S, Hortobágyi T. Giant cell tumour and central giant cell reparative granuloma of the skull: do these represent ends of a spectrum? A case report and literature review. Pathol Oncol Res 2009; 15 (2) 291-295
    CrossrefPubMedGoogle Scholar
  • 31 Williams JC, Thorell WE, Treves JS, Fidler ME, Moore GF, Leibrock LG. Giant cell reparative granuloma of the petrous temporal bone: a case report and literature review. Skull Base Surg 2000; 10 (2) 89-93
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Dahlin DC. Caldwell Lecture. Giant cell tumor of bone: highlights of 407 cases. AJR Am J Roentgenol 1985; 144 (5) 955-960
    CrossrefPubMedGoogle Scholar
  • 33 Goldenberg RR, Campbell CJ, Bonfiglio M. Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg Am 1970; 52 (4) 619-664
    CrossrefPubMedGoogle Scholar
  • 34 Emley WE. Giant cell tumor of the sphenoid bone. A case report and review of the literature. Arch Otolaryngol 1971; 94 (4) 369-374
    CrossrefPubMedGoogle Scholar
  • 35 Bertoni F, Unni KK, Beabout JW, Ebersold MJ. Giant cell tumor of the skull. Cancer 1992; 70 (5) 1124-1132
    CrossrefPubMedGoogle Scholar
  • 36 Wolfe III JT, Scheithauer BW, Dahlin DC. Giant-cell tumor of the sphenoid bone. Review of 10 cases. J Neurosurg 1983; 59 (2) 322-327
    CrossrefPubMedGoogle Scholar
  • 37 Zorlu F, Selek U, Soylemezoglu F, Oge K. Malignant giant cell tumor of the skull base originating from clivus and sphenoid bone. J Neurooncol 2006; 76 (2) 149-152
    CrossrefPubMedGoogle Scholar
  • 38 Balke M, Ahrens H, Streitbuerger A , et al. Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol 2009; 135 (1) 149-158
    CrossrefPubMedGoogle Scholar
  • 39 Malawer M, Helman LJ, O'Sullivan B. Giant cell tumor of the bone. In: DeVita Jr VT, Lawrence TS, Rosenberg SA, , eds. Cancer: Principles and Practice of Oncology. 8th ed. Philadelphia, PA: Lippincott Williams &Wilkins; 2008
    Google Scholar
  • 40 Brien EW, Mirra JM, Kessler S, Suen M, Ho JK, Yang WT. Benign giant cell tumor of bone with osteosarcomatous transformation (“dedifferentiated” primary malignant GCT): report of two cases. Skeletal Radiol 1997; 26 (4) 246-255
    CrossrefPubMedGoogle Scholar
  • 41 Siebenrock KA, Unni KK, Rock MG. Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up. J Bone Joint Surg Br 1998; 80 (1) 43-47
    CrossrefPubMedGoogle Scholar
  • 42 Grover R, Grobbelaar AO, Richman PI, Smith PJ. Measurement of invasive potential provides an accurate prognostic marker for giant cell tumour of tendon sheath. J Hand Surg [Br] 1998; 23 (6) 728-731
    CrossrefPubMedGoogle Scholar
  • 43 Abdullah A, Abdullah S, Haflah NH, Ibrahim S. Giant cell tumor of the tendon sheath in the knee of an 11-year-old girl. J Chin Med Assoc 2010; 73 (1) 47-51
    CrossrefPubMedGoogle Scholar
  • 44 Baba AI, Câtoi C. Comparative Oncology. Bucharest, Romania: The Publishing House of the Romanian Academy; 2007
    Google Scholar
  • 45 Haque AU, Moatasim A. Giant cell tumor of bone: a neoplasm or a reactive condition?. Int J Clin Exp Pathol 2008; 1 (6) 489-501
    PubMedGoogle Scholar
  • 46 Iizuka T, Furukawa M, Ishii H , et al. Giant cell tumor of the temporal bone with direct invasion into the middle ear and skull base: a case report. Case Rep Otolaryngol 2012; 2012: 690148
    PubMedGoogle Scholar
  • 47 Razek AA. Imaging appearance of bone tumors of the maxillofacial region. World J Radiol 2011; 3 (5) 125-134
    CrossrefPubMedGoogle Scholar
  • 48 Herman SD, Mesgarzadeh M, Bonakdarpour A, Dalinka MK. The role of magnetic resonance imaging in giant cell tumor of bone. Skeletal Radiol 1987; 16 (8) 635-643
    CrossrefPubMedGoogle Scholar
  • 49 Purohit S, Pardiwala DN. Imaging of giant cell tumor of bone. Indian J Orthop 2007; 41 (2) 91-96
    CrossrefPubMedGoogle Scholar
  • 50 Body JJ, Facon T, Coleman RE , et al. A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. Clin Cancer Res 2006; 12 (4) 1221-1228
    CrossrefPubMedGoogle Scholar
  • 51 Fizazi K, Lipton A, Mariette X , et al. Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. J Clin Oncol 2009; 27 (10) 1564-1571
    CrossrefPubMedGoogle Scholar
  • 52 Lipton A, Steger GG, Figueroa J , et al. Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases. J Clin Oncol 2007; 25 (28) 4431-4437
    CrossrefPubMedGoogle Scholar
  • 53 Lipton A, Steger GG, Figueroa J , et al. Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy. Clin Cancer Res 2008; 14 (20) 6690-6696
    CrossrefPubMedGoogle Scholar
  • 54 Balke M, Schremper L, Gebert C , et al. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 2008; 134 (9) 969-978
    CrossrefPubMedGoogle Scholar
  • 55 Watkins LD, Uttley D, Archer DJ, Wilkins P, Plowman N. Giant cell tumors of the sphenoid bone. Neurosurgery 1992; 30 (4) 576-581
    CrossrefPubMedGoogle Scholar
  • 56 Roeder F, Timke C, Zwicker F , et al. Intensity modulated radiotherapy (IMRT) in benign giant cell tumors—a single institution case series and a short review of the literature. Radiat Oncol 2010; 5: 18-56
    CrossrefPubMedGoogle Scholar
  • 57 Glasscock III ME, Hunt WE. Giant-cell tumor of the sphenoid and temporal bones. Laryngoscope 1974; 84 (7) 1181-1187
    CrossrefPubMedGoogle Scholar